Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years.

Linda Mileshkin,Tharani Sivakumaran,Dariush Etemadmoghadam,Richard W. Tothill,Andrew Fellowes,Stephen B. Fox,Lisa Guccione,Alison E. Freimund,Anna deFazio,Nicholas Wilcken,Bo Gao,Madhu Sudan Singh,Ian M. Collins,Gary Edward Richardson,Christopher Steer,Mark Andrew Warren,Christos S. Karapetis,Cindy Bryant,Penelope Schofield,David D.L. Bowtell

Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years.

2019

3072Background: Cancer of unknown primary (CUP) has a poor prognosis with a median survival of less than 12 months. SUPER is a prospective cohort study designed to create a national biobank of pati...

Keywords:

Unknown primary cancer
Prospective cohort study
Oncology
Pathology
Internal medicine
Medicine
Mutation
median survival
cancer of unknown primary
poor prognosis
Physical therapy
mutation profiling
Biobank

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations